Winston Wong, PharmD

Articles by Winston Wong, PharmD

Managed Care Considerations to Improve Health Care Utilization for Patients With ALS

ByWinston Wong, PharmD

June 7th 2023

Economic Burden of Alzheimer Disease and Managed Care Considerations

ByWinston Wong, PharmD

August 17th 2020

The Role of Managed Care Professionals in Improving Care for Patients With ALS

ByWinston Wong, PharmD

August 17th 2020

Managed Care Opportunities and Approaches to Select Treatment for Sight Preservation

ByWinston Wong, PharmD

May 29th 2020

Physician Behavior Impact When Revenue Shifted From Drugs to Services

ByBruce Feinberg, DO,Scott Milligan, PhD,Tim Olson, MBA,Winston Wong, PharmD,Daniel Winn, MD,Ram Trehan, MD,Jeffrey Scott, MD

April 21st 2014

Shifting physician revenue from drug sales to cognitive services for mature pathways providers did not affect practice behavior in this payer-sponsored Oncology Medical Home.

Third-Party Validation of Observed Savings From an Oncology Pathways Program

ByBruce A. Feinberg, DO,Scott Milligan, PhD,Joseph Cooper, BS,Winston Wong, PharmD,Daniel Winn, MD,Neil Schneider, ASA, MAAA,Sheamus Parkes, FSA, MAAA,Jeffrey Scott, MD

June 18th 2013

Dicontinuation Rates of Topical Glaucoma Medications in a Managed Care Population

ByFadia T. Shaya, PhD, MPH,C. Daniel Mullins, PhD,Winston Wong, PharmD,Jeannie Cho, PharmD

August 1st 2002

Latest Updated Articles

Managed Care Considerations to Improve Health Care Utilization for Patients With ALS
June 7th 2023
Economic Burden of Alzheimer Disease and Managed Care Considerations
August 17th 2020
The Role of Managed Care Professionals in Improving Care for Patients With ALS
August 17th 2020
Dicontinuation Rates of Topical Glaucoma Medications in a Managed Care Population
August 1st 2002
Managed Care Opportunities and Approaches to Select Treatment for Sight Preservation
May 29th 2020
Third-Party Validation of Observed Savings From an Oncology Pathways Program
June 18th 2013

Winston Wong, PharmD

Articles by Winston Wong, PharmD

Managed Care Considerations to Improve Health Care Utilization for Patients With ALS

Economic Burden of Alzheimer Disease and Managed Care Considerations

The Role of Managed Care Professionals in Improving Care for Patients With ALS

Managed Care Opportunities and Approaches to Select Treatment for Sight Preservation

Physician Behavior Impact When Revenue Shifted From Drugs to Services

Third-Party Validation of Observed Savings From an Oncology Pathways Program

Dicontinuation Rates of Topical Glaucoma Medications in a Managed Care Population

Latest Updated Articles

Trending on AJMC

COVID-19 May Follow a Different Seasonal Pattern Than Influenza, RSV

New Bill Would Cap Traditional Medicare Out-of-Pocket Costs at $5000

Topical Delgocitinib Improves Chronic Hand Eczema Outcomes Across All Trial Timepoints

COA Offers Playbook to Help Community Oncology Practices Navigate AI Partnerships

FDA Expands Risankizumab Approval to Pediatric Plaque Psoriasis, Active PsA